Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis
Articolo
Data di Pubblicazione:
2020
Citazione:
Efficacy, Safety, and Tolerability of Treatments for Systemic Sclerosis-Related Interstitial Lung Disease: A Systematic Review and Network Meta-Analysis / Erre, Gian Luca; Sebastiani, Marco; Fenu, Maria Antonietta; Zinellu, Angelo; Floris, Alberto; Cavagna, Lorenzo; Renzoni, Elisabetta; Manfredi, Andreina; Passiu, Giuseppe; Woodman, Richard John; Mangoni, Arduino Aleksander. - In: JOURNAL OF CLINICAL MEDICINE. - ISSN 2077-0383. - 9:8(2020), p. 2560. [10.3390/jcm9082560]
Abstract:
There is a paucity of head-to-head comparisons of the efficacy and harms of pharmacological treatments for systemic sclerosis-related interstitial lung disease (SSc-ILD).
Tipologia CRIS:
1.1 Articolo in rivista
Keywords:
cyclophosphamide; hematopoietic stem-cell transplantation; interstitial lung disease; mycophenolate mofetil; network meta-analysis; nintedanib; pomalidomide; randomized controlled trials; rituximab; systemic sclerosis
Elenco autori:
Erre, Gian Luca; Sebastiani, Marco; Fenu, Maria Antonietta; Zinellu, Angelo; Floris, Alberto; Cavagna, Lorenzo; Renzoni, Elisabetta; Manfredi, Andreina; Passiu, Giuseppe; Woodman, Richard John; Mangoni, Arduino Aleksander
Link alla scheda completa:
Pubblicato in: